Views: 1141 Downloads: 102

Sattar J. Abood , Waleed K. Abdulsahib^*✉

1. Department of Pharmacology & Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq.

Abstract

Snakebite is a serious injury and a common reason for the increasing death rate. Thus, it should be treated and assessed as highly prior, even in cases that seem well. The paper presents a retrospective investigation of snakebites in Iraq from 2019 to 2021 conveyed by the General Administration of Statistics and Information, Ministry of Health, Republic of Iraq. After obtaining the institutional committee's approval, the authors performed the extraction, analysis, and reporting of the data.

A total number of 802 patients were informed throughout three years, with the highest percentage in males (63%). The maximum rate of snake envenomation (P < 0.05) was documented in (41.64%). The highest percentage of anti-venom injections administered in 2021 was 57% (n = 1118). Snakebite cases were mainly reported during June and July in al Yarmouk Hospital, with a total of 17.36% (n = 50) and 17.46% (n = 52), respectively. In Murjan  Hospital, the months were September and August with a total of 50% (n = 8) and 40.35% (n = 7), respectively. In Baqubah Hospital, the months were May and August, with a total of 17.3% (n = 52) and 16.8% (n = 50), respectively. Finally, in the Al Hussein Hospital, the months were July and September, with a total of 23.5% (n = 43) and 22.2% (n = 39), respectively. Only 10 cases out of 802 died. The incidence of snakebites showed an increasing trend during the study period, and the incidence mostly occurred in July, August, and September‎.

Keywords: Snakebite, Anti-venom, Iraq, Mortality

Citation Formats: